1. Signaling Pathways
  2. Antibody-drug Conjugate/ADC Related
  3. Drug-Linker Conjugates for ADC
  4. Duocarmycins Isoform

Duocarmycins

 

Duocarmycins Related Products (8):

Cat. No. Product Name Effect Purity
  • HY-128904
    MC-Val-Cit-PAB-duocarmycin chloride
    98.16%
    MC-Val-Cit-PAB-duocarmycin chloride is a drug-linker conjugate for ADC with potent antitumor activity by using Duocarmycin (a DNA minor groove binding alkylating agent), linked via the ADC linker MC-Val-Cit-PAB.
  • HY-128957
    Vc-seco-DUBA
    99.80%
    Vc-seco-DUBA (SYD985) is a drug-linker conjugate for ADC with potent antitumor activity by using DUBA (DNA alkylating agent), linked via the ADC linker Vc-seco.
  • HY-136314
    DBCO-PEG4-VC-PAB-MMAE
    99.88%
    DBCO-PEG4-VC-PAB-MMAE consists a ADC linker (DBCO-PEG4-VC-PAB) and a tubulin polymerization inhibitor MMAE (HY-15162).
  • HY-126691
    DBCO-PEG4-VC-PAB-DMEA-PNU-159682
    DBCO-PEG4-VC-PAB-DMEA-PNU-159682, a drug-linker conjugate for ADC, consists the ADC linker DBCO-PEG4-VC-PAB and a potent ADC cytotoxin DMEA-PNU-159682.
  • HY-126532
    Fmoc-Val-Cit-PAB-Duocarmycin TM
    Fmoc-Val-Cit-PAB-Duocarmycin TM is a drug-linker conjugate for ADC by using the antitumor antibiotic, Duocarmycin TM, linked via Fmoc-Val-Cit-PAB.
  • HY-126684
    Mal-PEG4-VC-PAB-DMEA-Seco-Duocarmycin SA
    Mal-PEG4-VC-PAB-DMEA-Seco-Duocarmycin SA is a drug-linker conjugate for ADC by using the antitumor antibiotic, Duocarmycin SA, linked via Mal-PEG4-VC-PAB-DMEA-Seco.
  • HY-136289
    MB-VC-MGBA
    MB-VC-MGBA is a drug-linker conjugate for ADC with potent antitumor activity by using MGBA (minor-groove-binding DNA-alkylating agent), linked via the ADC linker MB-VC.
  • HY-131085
    Desmethyl Vc-seco-DUBA
    Desmethyl Vc-seco-DUBA consists a cleavable ADC linker (Desmethyl Vc-seco) and a DNA alkylating agent (DUBA).